New culture medium concepts for cell transplantation

Area of Science:

• Biomedical Engineering
• Cell Biology
• Regenerative Medicine

Background:

• Cell and tissue transplantation requires in vitro maintenance using culture media.
• Standard culture media components' safety for human transplantation is often unknown.
• Investigating novel culture media for transplantation safety is crucial.

Purpose of the Study:

• To develop and evaluate a novel, safe culture medium for cells intended for human transplantation.
• To assess the safety and efficacy of a fluid-based culture medium (FCM) using drug repositioning.

Main Methods:

• Developed a fluid-based culture medium (FCM) using clinically approved injectable drugs and fluids.
• Optimized FCM with concentrations similar to Dulbecco's modified Eagle's medium (DMEM), including amino acids, vitamins, inorganic salts, and D-glucose.
• Cultured human fat synovium-derived mesenchymal stem cells (FS-MSC) and rat H9c2 cells in optimized FCM-high glucose (FCM-HG) and commercial DMEM-high glucose (DMEM-HG).

Main Results:

• FCM-HG successfully induced the growth of both FS-MSC and H9c2 cells.
• Cellular morphology and proliferation rates in FCM-HG were comparable to those in DMEM-HG.
• No significant differences were observed between cells cultured in FCM-HG and DMEM-HG.

Conclusions:

• The developed fluid-based culture medium (FCM) is a viable option for culturing cells for transplantation.
• FCM, created via drug repositioning, shows promise as a safe and effective cell culture solution.
• This approach supports the development of safer cell-based therapies for human transplantation.